African Organizations

Search




Name Description Country Link
Botswana Harvard Partnership Established in 1996, the Botswana Harvard AIDS Institute Partnership (BHP) is a collaborative research and training initiative between Botswana's Ministry of Health and Wellness and the Harvard T.H. Chan School of Public Health AIDS Initiative. As a world class research center, BHP is the leading HIV/AIDS research, training and capacity building institution in Botswana. Areas of research include clinical and basic science, epidemiology, socio-behavioral science and community based bio-clinical research relevant to the AIDS epidemic and emerging public health challenges in Botswana, Sub-Saharan Africa and globally. Botswana
Cape Town HVTN Immunology The Cape Town HVTN Immunology Laboratory assesses immune responses to HIV vaccines being tested in Africa using high quality assays conducted according to Good Clinical Lab Practice standards. The laboratory also trains African scientists to carry out cutting edge clinical laboratory research and collaborates with local investigators to discover novel immune responses to vaccination. South Africa
Center for Infectious Disease Research in Zambia (CIDRZ) A leader in HIV/AIDS treatment and research, maternal-child health care and studies, and cervical cancer, malaria and tuberculosis practice, the CIDRZ research group comprises six Lusaka-based faculty members from the University of Alabama at Birmingham, 16 Zambian investigators and numerous collaborators from the University of Zambia, University Teaching Hospital, Zambian Ministry of Health, and numerous international partners. Zambia
Center for the AIDS Programme of Research in South Africa - CAPRISA CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Programme of Research on AIDS (CIPRA) by five partner institutions: University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care. South Africa
Cheikh Anta Diop University Senegal
Elizabeth Glaser Pediatrics AIDS Foundation Zambia In 2001, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) began working in Zambia to enhance access to HIV care and treatment services for both adults and children. To achieve this, EGPAF partnered with several organizations including the Zambian Ministry of Health, the Center for Infectious Disease Research in Zambia (CIDRZ), the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and the U.S. Centers for Disease Control and Prevention (CDC). Today, EGPAF-Zambia uses its expertise to build the capacity of the national health program at all levels. EGPAF's efforts to expand a strong and effective national health system to combat HIV and AIDS have focused on development and management of a health information system in country. They offer support and technical assistance to the country's strategic information and evaluation personnel and we implement an electronic health records system called SmartCare, which has been associated with improved patient tracking and follow-up in-country. Programs have also focused on children affected and infected with HIV. Through several projects, EGPAF ensures the health and psychosocial wellbeing of children across the country. Zambia
European & Developing Countries Clinical Trials Partnership (EDCTP) EDCTP aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials. EDCTP is a public-public partnership between countries in Europe and sub-Saharan Africa, and the European Union. Africa
FHI 360 Zambia For more than a decade, FHI 360 has been active in the areas of health and development in Zambia, addressing such issues as HIV/AIDS, tuberculosis, nutrition, family planning research, orphans and vulnerable children, water and sanitation, livelihoods, and education. They have collaborated with a wide range of government partners, including the Ministry of Health, the Ministry of Community Development and Mother and Child Health, the National HIV/AIDS/STI/TB Council, the Ministry of Education, the Ministry of Community and Social Welfare, the Office of the President, as well as with numerous international and local nongovernmental organizations. FHI 360 currently operates in all 10 provinces across Zambia. Staff includes public health specialists, physicians, nurses, finance and program experts, human resources professionals, organization development specialists and experts in our technical focus areas. FHI 360 is helping to develop and implement innovative solutions to Zambia's most pressing human development challenges through: behavior change interventions, capacity building of local organizations and service providers, service delivery, health systems strengthening, research, community mobilization and engagement, economic strengthening and public-private partnerships. Zambia
HIV Pathogenesis Programme (HPP) at the University of KwaZulu-Natal HPP is located in the Doris Duke Medical Research Institute (DDMRI) at the University of KwaZulu-Natal's Nelson R. Mandela School of Medicine Campus. HPP is a research initiative established in 2002 at the University of KwaZulu-Natal in collaboration with Harvard Medical School, USA. This collaborative programme was initially funded by the Doris Duke Charitable Foundation, but now attracts funding from other international and local funding agencies. South Africa
HIV/AIDS Vaccine Ethics Group (HAVEG) HAVEG undertakes empirical and conceptual research into ethico-legal complexities in HIV vaccine trials in South Africa, and is involved in the development of resources for vaccine stakeholders. They work with a range of role-players to facilitate the ethical conduct of HIV vaccine trials in that setting. HAVEG has focused on key issues including informed consent for trial participation, ancillary care and standards of prevention, and adolescent participation; as well as addressed other issues (e.g. compensation for research related injury, payment for trial participation and stakeholder engagement). They also coordinated the development of ethical guidelines for HIV vaccine trials in South Africa, on behalf of the MRC. South Africa
Institute of Infectious Disease and Molecular Medicine at the University of Cape Town (IDM) South Africa
Instituto Nacional de Saude The Instituto Nacional de Saude is an institution of the Ministry of Health dedicated to the generation of technical and scientific information in the area of health in Mozambique, so that decisions in the sector of health in Mozambique are increasingly based on evidence. Mozambique
International Centre for Reproductive Health, Kenya (ICRH Kenya) ICRH is a multidisciplinary research institute within Ghent University. The Centre was established in 1994 in response to the International Conference on Population and Development (ICPD, Cairo, 1994). ICRH conducts research and intervention projects in all areas of reproductive health, implements capacity building, provides community education, prevention and HIV testing services, and advocates for sexual and reproductive health and rights. ICRH is active in Africa, Latin America, Asia and Europe. ICRH is a WHO Collaborating Centre for Research on Sexual and Reproductive Health and has experience in attracting donor funds from a wide range of agencies. Kenya
KAVI - Institute of Clinical Research The KAVI Institute of Clinical Research (KAVI-ICR) is a word-class research hub at the College of Health Sciences, University of Nairobi, spearheading research and training in global health. KAVI-ICR has conducted basic HIV, epidemiology research and eight HIV vaccine trials, ten basic science, and epidemiological research studies. KAVI-ICR programs are geared to understanding the underlying determinants of good health for prevention of both communicable and non-communicable diseases are urgently needed. Linking various health determinants to establish the best interventions and preventive measures is a key outcome from global health research. Kenya
Makerere University Walter Reed Project (MUWRP) MUWRP is a non-profit biomedical research organization, whose mission is to mitigate disease threats through quality research, health care and disease surveillance. MUWRP was established in 2002 by a Memorandum of Agreement between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and Makerere University to undertake medical research to test HIV vaccines. Uganda
MRC/UVRI Uganda Research Unit on AIDS The MRC/UVRI Uganda Research Unit on AIDS is an internationally recognized center of excellence for research on HIV infection and related diseases, contributing knowledge on the evolving epidemic, the evaluation of innovative health care options, treatment and prevention, and the development of health policy and practice in Africa and worldwide. The unit was established in 1989 following a request from the Uganda Government to the UK Government to contribute to the understanding and control of the HIV pandemic in Uganda. In 2005, the MRC program was upgraded to a research unit with headquarters in Entebbe at the Uganda Virus Research Institute (UVRI) and the main research activities located in Masaka, Kalungu, Kampala and Wakiso districts, including the peri-urban areas of Entebbe. Uganda
Muhimbili University of Health and Allied Sciences (MUHAS) Tanzania
National Institute for Communicable Diseases (NICD) The NICD is a major global player in infectious disease intelligence. The NICD is a resource of knowledge and expertise in regionally relevant communicable diseases to the South African Government, to SADC countries and the African continent. The NICD assists in the planning of policies and programmes and supports appropriate responses to communicable disease problems and issues. South Africa
New HIV Vaccine and Microbicide Advocacy Society (NHVMAS) The New HIV Vaccine and Microbicide Advocacy Society (formerly Nigeria HIV Vaccine and Microbicides Advocacy Group) was born out of a collective vision of a few Nigerian activists to ensure proactive and early involvement of the Nigerian Government and its citizens in New HIV Prevention Technology research and development. NHVMAS is a popularly owned campaign, with its members, supporters and partners as the driving force. It was established in 2003 as a broad movement of vaccine and microbicides advocates. Nigeria
Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital PHRU engages in research, training, policy-formulation and advocacy concerning HIV-positive people and their children. Specifically, PHRU conducts adult, paediatric and adolescent HIV treatment research, HIV prevention research and investigations into tuberculosis and other HIV co-infections. In addition to the numerous pharmaceutical and publicly-funded clinical trials PHRU continues to carry out, the unit also conducts important behavioural and social science research, advocates for research access and provides needed care to the people of Soweto. South Africa
Rwanda Zambia HIV Research Group (RZHRG) RZHRG is committed to supporting couples voluntary counseling and testing as an effective and economical way to decrease HIV/AIDS transmission throughout southern Africa. Since 2004, RZHRG has participated in multiple clinical research trials including Phase I, II and III trials of behavioral and biomedical prevention interventions. RZHRG's 25 years of research practice and experience, as well as the ongoing recruitment of study participants, enables its study sites to perform many of the procedures required for a preventive-vaccine efficacy trial. Rwanda
South African AIDS Vaccine Initiative (SAAVI) SAAVI was established in 1999 as an initiative of the South African government and managed as a lead programme of the South African Medical Research Council (SAMRC). SAAVI's role was to co-ordinate and support the development and testing of HIV vaccines in South Africa with the aim of finding an affordable, effective and locally relevant HIV vaccine. South Africa
South African Medical Research Council (SAMRC) SAMRC was established in 1969 with the aim to deliver on a mandate to promote the improvement of the health and the quality of life of the population of our country through research, development and technology transfer. The scope of the SAMRC's research includes basic laboratory investigations, clinical research and public health studies. Research at the SAMRC focuses on the ten highest causes of mortality in South Africa and includes TB, HIV, chronic diseases, alcohol and drug abuse, and women's health. South Africa
Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) SANTHE is an acronym for "Sub-Saharan African Network for TB/HIV Research Excellence" - a Sub-Saharan African network of African-led research in HIV (particularly acute HIV (AHI)) and Tuberculosis (TB) infection. SANTHE aims to shape and drive locally relevant basic, clinical and translational research in Africa. South Africa
The Aurum Institute The Aurum Institute is a proudly African, public-benefit organisation with over 18 years' experience in leading the response, treatment and research efforts to eradicate TB and HIV. They have been working alongside government, the mining industry, among NGO's and in communities to better understand global health challenges to provide real solutions. South Africa
The Chantal Biya International Reference center for research on the prevention and Management of HIV/AIDS (CIRCB) The CIRCB was established in 2006 to conduct research on the prevention and management of HIV/AIDS. In addition to providing specialized services to people living with HIV such as viral load, CD4 T cell count, antiretroviral drug resistant test etc the CIRCB also does early infant diagnosis of HIV-1 in children born of HIV-1 infected mothers. A major prevention activity of the CIRCB is the development of a vaccine for therapeutic or prophylactic vaccination against HIV-1. The CIRCB is also actively training a new generation of scientists to perform cutting edge research in the domain of HIV infection and comorbidities. Cameroon
The Desmond Tutu HIV Foundation The Desmond Tutu HIV Foundation, housed within the Desmond Tutu HIV Centre (DTHC) at the University of Cape Town, is committed to the pursuit of excellence in research, treatment, training and prevention of HIV and related infections in Southern Africa. The Foundation, supported by the Archbishop Emeritus Desmond Tutu and his wife, Leah has been in existence as a "not for profit" organization since 2004. South Africa
Tropical Disease Research Center The Tropical Diseases Research Centre (TDRC) is a biomedical research Centre established by the World Health Assembly in 1977. It is located in Ndola, Zambia. TDRC was initiated by the World Health Organisation (WHO) in collaboration with the Zambian Government. This was in response to a resolution of the World Health Assembly of 1974 which called for the intensification of research into tropical diseases and stipulated that, as far as possible, the work should be done in developing countries where these diseases are endemic. In January 1981, the TDRC became a National Institution for research, training, and service in diseases of public health importance in Zambia. To this effect, the TDRC must be seen first and foremost as a national resource dedicated to priority health problems in Zambia and as a facility for training national and regional health service personnel. It is a parastatal under the Ministry of Health with the mandate to conduct epidemiological and clinical research. Activities of the institute include epidemiological and clinical re-search in malaria, schistosomiasis African trypanosomiasis, HIV/AIDS, micronutrient deficiencies, health systems research, health impact and evaluation, training and service. Zambia
Wits Reproductive Health and HIV Institute of the University of the Witwatersrand The Wits Reproductive Health and HIV Institute (Wits RHI) was established by Professor Helen Rees in 1994 to support the new South African government formulate and implement new national policies around sexual and reproductive health. Wits RHI is one of the leading multi-disciplinary institutes in Africa with an extensive portfolio that includes research, programmatic support, training, policy development, health systems strengthening and technical assistance at national and international levels. Our areas of expertise encompass HIV, sexual and reproductive health (SRH) and vaccine preventable diseases. South Africa
Zambia AIDS Related Tuberculosis Project (ZAMBART) Zambart is a Zambian research organisation established in 2004 from a research collaboration between the School of Medicine University of Zambia and the London School of Hygiene and Tropical Medicine (LSHTM) that spans over 20 years. From the initial studies of the impact of HIV on the clinical presentation and outcome of Tuberculosis, the scope and partnership of the research have expanded. Based in the School of Medicine Ridgeway campus of the University of Zambia in Lusaka, Zambart has grown to become one of the leading research groups supporting healthcare advances in TB and HIV. Since 1989, Zambart has actively partnered with the Zambian government through direct collaboration in healthcare research. Zambart also works closely with other research organizations and academic institutions within Africa, and worldwide to help innovatively reduce the public-health burden caused by the dual epidemics in resource-limited communities in Zambia and beyond. Zambia